FREE Account Opening + No Clearing Fees
Loading...
July 13, 2020 - July 15, 2020

Rossari Biotech IPO Review & Recommendations

Rossari Biotech IPO Review Summary from brokers and analysts

Review By Apply May Apply Neutral Avoid Not Rated
Count 9 3 0 0 3
% 60.00 20.00 0.00 0.00 20.00

Rossari Biotech IPO Analysis By Brokers/Analysts

Rossari Biotech IPO Capital Market Rating

The Captial Market (CapitalMarket.com) rating for Rossari Biotech IPO is 48. Their analysis recommends May subscribe for the IPO.

Reviewer Rating Score Rating
Capital Market 48 May subscribe

Rossari Biotech IPO Review by Dilip Davda (May apply)

[Dilip Davda]  On the current parameters, the issue appears fully priced. However, considering bright prospects going forward with more than double installed capacity and rising patronage by top clients with long term relations, investors may consider investment for long term rewards. Read detail review...

Post Recommendation Manage Recommendations

Note:

  • The recommendations or analysis of public issues posted above expresses the views of its author and does not represent the views of Chittorgarh.com or its staff.
  • We reserve the right to remove any objectionable post without providing a reason.